Executive Briefing - Biopartnering 2.0
27 August 2009
Pete Chan
pete.chan@informa.com
The biopharmaceutical industry's perennial search for innovation continues to drive diverse alliance activity between commercial partners of all stripes. More recently, the macroeconomic climate has been impacting on dealmaker behaviour, with the emergence of risk aversion, creative...
Please Login to read the full article.